throbber
BSC USP 8,048,032B
`Exhibit 1003
`
`Page 1 of 40
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In the Inter Partes Review of:
`U.S. Patent No. 8,048,032
`Filed: May 3, 2006
`Issued:
`
`
`
`
`
`Trial Number: To Be Assigned
`
`
`
`
`
`Attorney Docket No.:
`
`
`
`
`Inventors: Howard Root, Greg Sutton,
`Jeffrey M. Welch, Jason M. Garrity
`
`Assignee: Vascular Solutions, Inc.
`
`Title: Coaxial Guide Catheter For
`Interventional Cardiology Procedures
`
`DECLARATION BY RONALD SOLAR, PH.D. REGARDING U.S.
`PATENT NO. 8,048,032 UNDER 37 C.F.R. § 42.63(a)
`
`
`
`1
`
`

`
`Page 2 of 40
`
`
`
`
`
`I, Ronald Jay Solar, Ph.D., do declare and state as follows:
`
`I.
`
`Background and Experience
`
`1.
`
`I received my B.S. in Metallurgy and Materials Science from
`
`Pennsylvania State University in 1972, and my Ph.D. in Metallurgy, Materials
`
`Science and Biomaterials from University of Pennsylvania in 1976. My studies
`
`focused on surgical implants.
`
`2.
`
`Since graduation, virtually all of my experience has involved working
`
`with various companies on the design, development, and testing of medical
`
`devices, the vast majority of which have been in the field of interventional
`
`cardiology.
`
`3.
`
`Combined, I have over thirty-seven years of academic and industry
`
`experience in all aspects of design, research, development, clinical testing,
`
`regulation, patenting, manufacture, production, quality control and assurance,
`
`marketing, and sales of medical devices. The predominant focus of my work in the
`
`medical device industry has been in the design and development of interventional
`
`cardiology devices within the peripheral and coronary vascular marketplace. I am a
`
`named inventor of fifty U.S. patents on diagnostic and therapeutic catheters,
`
`guidewires, vascular stents, and stent delivery systems, and I have extensive
`
`experience with the design and functionality of such devices.
`
`4.
`
`Attached to this declaration is a copy of my curriculum vitae at
`
`Appendix A.
`
`5.
`
`I am presently the President and Founder of Renaissance Biomedical,
`
`Inc., which is a consulting firm focusing on all aspects of the medical device
`
` 2
`
`

`
`Page 3 of 40
`
`
`
`
`
`industry, including research, design, technical, marketing, patent, clinical, and
`
`regulatory issues.
`
`6.
`
`I am not employed by, nor receiving grant support from, Boston
`
`Scientific Corporation or its subsidiary, Boston Scientific Scimed, Inc. I am
`
`receiving compensation for my involvement in this matter based on my standard
`
`hourly consulting fees. I have no financial interest in the outcome of this case. A
`
`listing of testimony that I have provided in prior proceedings and my compensation
`
`is attached hereto as Appendix B.
`
`7.
`
`I am competent to make this declaration based upon my personal
`
`knowledge and technical expertise in the area of interventional cardiology devices
`
`and procedures. In preparing my opinions, I have considered the following
`
`materials:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1010)
`
`
`
`
`
`U.S. Patent No. 8,048,032 to Root, et al. (Exh. 1001 )
`
`File History for U.S. Patent No. 8,048,032 (Exh. 1002)
`
`U.S. Patent No. 8,292,850 to Root, et al. (Exh. 1004)
`
`U.S. Patent No. 8,142,413 to Root, et al. (Exh. 1005)
`
`File History for U.S. Patent No. 8,292,850 (Exh. 1006)
`
`File History for U.S. Patent No. 8,142,413 (Exh. 1007)
`
`U.S. Publication No. 2004/0236215 A1 to Mihara et al. (Exh. 1009)
`
`Translation of Japanese Patent Application No. 2003-070808 (Exh.
`
`U.S. Patent No. 5,527,292 to Adams et al. (Exh. 1011)
`
`U.S. Publication No. 2003/0195546 A1 to Solar, et al. (Exh. 1012)
`
` 3
`
`

`
`Page 4 of 40
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 6,638,268 to Niazi (Exh. 1013)
`
`U.S. Publication No. 2005/0004523 A1 to Osborne, et al. (Exh. 1014)
`
`U.S. Publication No. 2004/0127927 to Adams (Exh. 1015)
`
`U.S. Patent No. 6,338,725 B1 to Hermann et al. (Exh. 1016)
`
`U.S. Patent No. 5,776,141 to Klein et al. (Exh. 1017)
`
`U.S. Patent No. 7,232,452 to Adams et al. (Exh. 1018)
`
`U.S. Patent No. 5,328,472 to Steinke et al. (Exh. 1019)
`
`Takahashi et al., “New Method to Increase a Backup Support of a 6
`
`French Guiding Coronary Catheter,” Catherization and Cardiovascular
`
`Interventions 63:452-456 (2004) (Exh. 1020)
`
`U.S. Patent No. 5,690,613 to Verbeek (Exh. 1021)
`
`U.S. Patent No. 5,156,594 to Keith (Exh. 1022)
`
`U.S. Patent No. 5,102,403 to Alt (Exh. 1023)
`
`Kucklick, Theodore R., The Medical Device R&D Handbook (2006)
`
`
`
`
`
`
`
`
`
`(Exh. 1024)
`
`
`
`Non-confidential publicly available versions of the following filings
`
`and decisions in the ongoing litigation:
`
`a. Amended Complaint filed by Vascular Solutions, Inc. in Vascular
`
`Solutions, Inc. v. Boston Scientific Corporation, No. 13-cv-1172
`
`(JRT-SER) (D. Minn). (May 28, 2013) (Exh. 1025)
`
`b. Memorandum In Support of Motion for Preliminary Injunction filed
`
`by Vascular Solutions, Inc. in Vascular Solutions, Inc. v. Boston
`
` 4
`
`

`
`Page 5 of 40
`
`
`
`
`
`Scientific Corporation, No. 13-cv-1172 (JRT-SER) (D. Minn).
`
`(June 10, 2013) (Exh. 1026)
`
`c. Declaration of Howard Root In Support of Vascular Solution, Inc.’s
`
`Motion for Preliminary Injunction with Non-Confidential Exhibits
`
`filed in Vascular Solutions, Inc. v. Boston Scientific Corporation, No.
`
`13-cv-1172 (JRT-SER) (D. Minn). (June 10, 2013) (Exh. 1027)
`
`d. Boston Scientific Corporation Opposition to Vascular Solutions,
`
`Inc.’s Motion for Preliminary Injunction filed in Vascular Solutions,
`
`Inc. v. Boston Scientific Corporation, No. 13-cv-1172 (JRT-SER) (D.
`
`Minn). (July 28, 2013) (Exh. 1028)
`
`e. Non-Confidential Memorandum Opinion and Order Granting In Part
`
`Plaintiff’s Motion for Preliminary Injunction filed in Vascular
`
`Solutions, Inc. v. Boston Scientific Corporation, No. 13-cv-1172
`
`(JRT-SER) (D. Minn). (December 19, 2013) (Exh. 1029)
`
`f. Boston Scientific Corporation’s Motion for An Interim Stay and Stay
`
`Pending Appeal, No. 2014-1185 (Fed. Cir). filed December 27, 2013
`
`(Exh. 1030)
`
`g. Vascular Solutions, Inc.’s Opposition to Boston Scientific
`
`Corporation’s Motion for An Interim Stay and Stay Pending Appeal,
`
`No. 2014-1185 (Fed. Cir). filed January 3, 2014 (Exh. 1031)
`
`h. Boston Scientific Corporation’s Non-Confidential Opening Brief, No.
`
`2014-1185 (Fed. Cir). filed January 7, 2014 (Exh. 1032)
`
` 5
`
`

`
`Page 6 of 40
`
`
`
`
`
`i. Vascular Solutions, Inc.’s Non-Confidential Responsive Brief, No.
`
`2014-1185 (Fed. Cir). filed January 29, 2014 (Exh. 1033)
`
`j. Boston Scientific Corporation’s Reply Brief, No. 2014-1185 (Fed.
`
`Cir). filed February 3, 2014 (Exh. 1034)
`
`k. Transcript of Oral Argument Proceedings held on April 8, 2014 (Fed.
`
`Cir). (Exh. 1035)
`
`l. Federal Circuit Order Vacating Preliminary Injunction (April 15,
`
`2014) (Exh. 1036)
`
`m. Joint Claim Construction Statement filed in Vascular Solutions, Inc. v.
`
`Boston Scientific Corporation, No. 13-cv-1172 (JRT-SER) (D. Minn).
`
`(February 21, 2014) (Exh. 1037)
`
`
`
`
`
`U.S. Patent No. 6,997,908 B2 to Carrillo, Jr., et al. (Exh. 1038)
`
`Monorail Piccolino Publication, Introducing the Schneider
`
`MONORAIL-GEX Guidewire Exchange Catheter Brochure (Exh. 1039)
`
`
`
`
`
`
`
`
`
`U.S. Publication No. 2002/0165598 A1 to Wahr et al. (Exh. 1040)
`
`U.S. Patent No. 5,267,958 to Buchbinder et al. (Exh. 1041)
`
`Manual of Patent Examining Procedure (MPEP) Sections cited herein
`
`KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, (2007);
`
`The documents I have reviewed are reflected in my analysis.
`
`II.
`
`Summary of Patent, Prior Art, and Analysis
`
`A. Overview of the Relevant Technology
`
`8.
`
`The claims of U.S. Patent No. 8,048,032 (“the ‘032 Patent”) (Exh.
`
`1001) are directed to the field of interventional cardiology procedures, such as the
`
` 6
`
`

`
`Page 7 of 40
`
`
`
`
`
`treatment of obstructive coronary artery disease. (See Exh. 1001, 1:7-36). During
`
`such procedures, physicians deploy thin, flexible treatment devices, such as
`
`guidewires, balloon catheters, filters, stents, stent catheters, or other devices to
`
`treat a blockage (occlusion) or narrowing (stenosis) in the arteries due to
`
`atherosclerotic plaques or other lesions. (Id). The physician introduces the
`
`treatment device into the patient’s vascular system through the groin or wrist and
`
`advances it to the site of a blockage to perform a procedure—such as the inflation
`
`of a balloon or the placement of a stent—to relieve the blockage and restore blood
`
`flow. Id. Often, to create a passage for such treatment devices, physicians insert a
`
`“guide catheter” earlier in the procedure. (Id). In coronary interventions, this guide
`
`catheter typically runs from the groin or wrist to one of the coronary ostia (two
`
`openings in the aorta that open into the coronary arteries), but is too wide for
`
`advancement beyond either coronary ostium. (Id). The ‘032 patent is directed to an
`
`apparatus that is deliverable through a standard guide catheter for extension
`
`beyond the ostium to provide back up support—i.e., to prevent the guide catheter
`
`from being dislodged during the procedure. (See, e.g., Exh. 1001, 2:45-49).
`
`B. Overview of United States Patent No. 8,048,032
`
`9.
`
`United States Patent No. 8,048,032 (“the ‘032 patent”), filed as U.S.
`
`App. Serial No. 11/416,629 on May 3, 2006, is entitled “Coaxial Guide Catheter
`
`for Interventional Cardiology Procedures,” and includes 22 device claims (Exh.
`
`1001). For the purpose of this declaration only, I have been asked to assume that
`
`the priority date of the ‘032 patent is May 3, 2006.
`
` 7
`
`

`
`Page 8 of 40
`
`
`
`
`
`10. The specification of the ‘032 patent describes it as relating “generally
`
`to catheters used in interventional cardiology procedures,” and “[m]ore
`
`particularly, ... apparatus for increasing backup support for catheters inserted into
`
`the coronary arteries of the aorta.” (Exh. 1001, 1:7-11).
`
`11. The full text of independent claim 1 of the ‘032 patent is set forth
`
`below:
`
`1. A device for use with a standard guide catheter, the standard
`
`guide catheter having a continuous lumen extending for a
`
`predefined length from a proximal end at a hemostatic valve to a
`
`distal end adapted to be placed in a branch artery, the continuous
`
`lumen of the guide catheter having a circular cross-sectional
`
`inner diameter sized such that interventional cardiology devices
`
`are insertable into and through the lumen to the branch artery, the
`
`device comprising:
`
`a flexible tip portion defining a tubular structure having a
`
`circular cross-section and a length that is shorter than the
`
`predefined length of the continuous lumen of the guide catheter,
`
`the tubular structure having a cross-sectional outer diameter
`
`sized to be insertable through the cross-sectional inner diameter
`
`of the continuous lumen of the guide catheter and defining a
`
`coaxial lumen having a cross-sectional inner diameter through
`
`which interventional cardiology devices are insertable; and
`
`a substantially rigid portion proximal of and operably connected
`
`to, and more rigid along a longitudinal axis than, the flexible tip
`
`portion and defining a rail structure without a lumen and having
`
` 8
`
`

`
`Page 9 of 40
`
`
`
`
`
`a maximal cross-sectional dimension at a proximal portion that is
`
`smaller than the cross-sectional outer diameter of the flexible tip
`
`portion and having a length that, when combined with the length
`
`of the flexible distal tip portion, defines a total length of the
`
`device along the longitudinal axis that is longer than the length
`
`of the continuous lumen of the guide catheter,
`
`
`
`such that when at least a distal portion of the flexible tip portion
`
`is extended distally of the distal end of the guide catheter, at least
`
`a portion of the proximal portion of the substantially rigid portion
`
`extends proximally through the hemostatic valve in common with
`
`interventional cardiology devices that are insertable into the
`
`guide catheter.
`
`12. The other claims at issue in this proceeding that depend from claim 1
`
`include claim 2 which effectively describes a functional use for the device of claim
`
`1, without reciting any additional structural components. Specifically, claim 2
`
`recites: “that the device assists in resisting axial and shear forces exerted by the
`
`interventional cardiology device passed through and beyond the coaxial lumen that
`
`would otherwise tend to dislodge the guide catheter from the branch artery.”
`
`13. Claim 3 (which depends from claims 1 and 2) adds the element of a
`
`“proximal side opening ... extending for a distance along the longitudinal axis” and
`
`“transverse to the longitudinal axis”, and claim 4 (which depends from claims 1, 2,
`
`and 3) adds the elements of a “structure defining a full circumference portion and
`
`structure defining a partially cylindrical portion.”
`
` 9
`
`

`
`Page 10 of 40
`
`
`
`
`
`14. Claim 8 (which depends from claim 1) adds the element that the “the
`
`cross-sectional inner diameter of the coaxial lumen of the tubular structure is not
`
`more than one French smaller than the cross-sectional inner diameter of the guide
`
`catheter.”
`
`15. The elements of independent claim 11 of the ‘032 patent include all
`
`the limitations of claim 1. In addition to the limitations of claim 1, claim 11 also
`
`includes the additional limitation of “a reinforced portion proximal to the flexible
`
`tip portion.”
`
`16.
`
` Claim 13 (which depends from claim 11) adds the element of “the
`
`substantially rigid portion further includ[ing] a partially cylindrical portion
`
`defining an opening extending for a distance along a side thereof defined
`
`transverse to a longitudinal axis ... the opening extending substantially along at
`
`least a portion of a length of the substantially rigid portion.”
`
`17. Claim 17 (which depends from claim 11) adds the element (identical
`
`to claim 8) that the “the cross-sectional inner diameter of the coaxial lumen of the
`
`tubular structure is not more than one French smaller than the cross-sectional inner
`
`diameter of the guide catheter.”
`
`C. Background of Art
`
`18. The Field of the Invention “relates generally to catheters used in
`
`interventional cardiology procedures,” and “[m]ore particularly ... apparatus for
`
`increasing backup support for catheters inserted into the coronary arteries from the
`
`aorta.” (Exh. 1001, 1:7-11). The specification of the ‘032 patent admits that
`
`inserting an inner guide catheter device within and through a standard guide
`
` 10
`
`

`
`Page 11 of 40
`
`
`
`
`
`catheter (coaxially) to provide backup support during interventional cardiology
`
`procedures was not new at the time of the ‘032 patent. Moreover, by the filing
`
`date of ‘032 patent, existing catheter technology routinely employed shortened
`
`flexible distal tubes for the receipt of an interventional cardiology device known as
`
`a guidewire. The design of the proximal opening in such catheters was angled or
`
`“skived.”
`
`19. Broadly speaking, there were two basic catheter designs available by
`
`2006: “over the wire” catheters and “rapid exchange” (or “monorail”) catheters. In
`
`an over the wire catheter, the guide wire remains inside the catheter for the entire
`
`length of the catheter as depicted in the image below:
`
`Guidewire
`
`
`
`20.
`
`In contrast, a rapid exchange catheter is delivered over a guidewire,
`
`but the flexible tube that defines the device’s guidewire lumen is shorter than the
`
`full length of the catheter and passes over only part of the wire. The below image
`
`depicts a rapid exchange catheter, showing the guidewire inside the catheter for
`
`only a portion of the catheter’s length. I understand that both of these illustrations
`
`(absent the annotations in red) were used in the declaration of named inventor
`
`Howard Root that was submitted on behalf of the Patent Owner in the pending
`
`litigation (Exh. 1027, 11-12).
`
` 11
`Guidewire
`
`
`
`

`
`Page 12 of 40
`
`
`
`
`
`21.
`
`In using over the wire catheters, physicians have to rely on an
`
`assistant to help them deliver the guidewire—since it must be long enough to run
`
`the entire length of both catheters. Rapid exchange catheters were, therefore,
`
`considered advantageous because their shortened guidewire lumen permitted the
`
`use of shorter guidewires for more efficient delivery and exchange.
`
`22. There were countless disclosures of skived proximal openings existing
`
`in the art prior to the filing of the ‘032 patent, particularly given the prevalence of
`
`such teachings in the art of rapid exchange balloon catheter patents and
`
`publications. A few prior art disclosures that are demonstrative of the
`
`pervasiveness of such teachings in the art include: U.S. Patent No. 5,690,613
`
`(“Verbeek”) (Exh. 1021) directed to “a shaft transition section for a rapid exchange
`
`high pressure balloon catheter” wherein the proximal portion of the guidewire
`
`lumen is skived at an angle. Verbeek expressly teaches to: “Skive 95 the proximal
`
`end of the inner lumen tubing 70 at an angle of approximately 10 degrees for a
`
`length of 2mm.” (Exh. 1021, 1:6-9, 6:9-11).
`
`23.
`
`In 1990, U.S. Patent No. 5,102,403 (“Alt”) (Exh. 1023) also disclosed
`
`a catheter “of the type riding on a guide wire only at a short distal end portion”
`
`(Exh. 1023, 2:63-65), including an express disclosure and clear depiction of a
`
`proximal side opening having both full circumference and hemicylindrical portions
`
`through which a guidewire is received. (Id. at Figs. 4, 7). Alt was directed to a
`
`catheter that includes an outer wall that changes gradually while passing through
`
`successive configurations at the more distal end. The substantially cylindrical outer
`
`wall becomes grooved to guide a guide wire alongside toward the interior of the
`
` 12
`
`

`
`Page 13 of 40
`
`
`
`
`
`catheter without any significant bending of the wire. This groove becomes a
`
`crescent-shaped wall-lumina configuration which partially encompasses the guide
`
`wire before becoming cylindrical to surround the guide wire. (Exh. 1023, 3:10-14;
`
`4:36-51).
`
`24. A similarly gradual guidewire transition design was also described in
`
`1990 by Keith (U.S. Patent No. 5,156,594) (Exh. 1022) which incorporated
`
`hypodermic needle tubing to improve pushing forces. The Keith patent focused on
`
`improving the transition zone at the proximal guide wire lumen opening by
`
`incorporating a metallic tube formed into a crescent shape connected to a metallic
`
`spring. (Exh. 1022, 3:59-4:52).
`
`25. As such, replacing the use of a full length catheter with a skived short
`
`distal guidewire lumen tube segment was well known in the art well before the
`
`‘032 patent as standard features of rapid exchange catheters. See also, Carillo Jr
`
`(Exh. 1038, at least Figures 1A-E show a catheter having proximal side opening
`
`defining a full circumference portion and a partially cylindrical portion );
`
`Schneider, Inc., Product Brochure for Monorail® GEXTM (Exh. 1039, Figure
`
`depicts side opening), Wahr et al. (Exh. 1040, [105] (“The distal and proximal
`
`ends of the expanded evacuation head 232 may be angled relative to its
`
`longitudinal axis . . .”); Claim 145 (“An evacuation sheath assembly, comprising:
`
`an elongated tube defining an evacuation lumen having open proximal and distal
`
`ends . . .wherein the open proximal end of the evacuation lumen is angled.”), and
`
`Buchbinder et al. (Exh. 1041, Fig. 4 shows a catheter with a proximal opening of
`
`the guide wire lumen cut at an angle or skived).
`
` 13
`
`

`
`Page 14 of 40
`
`
`
`
`
`26. Even outside of rapid exchange, skiving was well known in the art as,
`
`from a manufacturing standpoint, one of the most basic and efficient designs for
`
`crafting an opening in the lumen of a catheter, and a common technique for
`
`controlling the flexibility of a device in areas where breakage or kinking were
`
`likely to occur. See, e.g., Kucklick, Theodore R., Medical Device R & D
`
`Handbook (Nov. 21, 2005) (Exh. 1024, at p. 117).
`
`III. One of Ordinary Skill in the Art
`
`27.
`
`I understand that the factors considered in determining the ordinary
`
`level of skill in the art include the level of education and experience of persons
`
`working in the field; the types of problems encountered in the field; and the
`
`sophistication of the technology.
`
`28.
`
`In my opinion, a person of ordinary skill in the art (“POSA”) at the
`
`time of the alleged invention of the ‘032 patent would have been someone with at
`
`least the equivalent of a medical degree from an accredited institution (usually
`
`denoted in this country as a M.D. degree) or someone with the equivalent of a
`
`masters degree from an accredited institution (usually denoted in this country as an
`
`M.S. degree) in biomedical engineering. The person must have at least three years
`
`of experience working as an interventional cardiologist, interventional radiologist,
`
`cardiothoracic surgeon, interventionalist, or biomedical engineer or biomedical
`
`device designer and/or manufacturer. Extensive experience and technical training
`
`might substitute for educational requirements, while advanced degrees might
`
`substitute for experience.
`
` 14
`
`

`
`Page 15 of 40
`
`
`
`
`
`29. A POSA would have a detailed understanding of the prior art, would
`
`have been able to draw inferences from the prior art, and would have had the
`
`ability to identify optimal combinations of device shapes and configurations found
`
`in the prior art for a particular application.
`
`30.
`
`In 2006, I would have exceeded the level of skill required, and I am in
`
`a position to opine on the understanding of a person of ordinary skill in the art.
`
`IV. Summary of Prior Art References
`
`31.
`
`I have evaluated references in connection with this proceeding that
`
`address the elements of the claims of the ‘032 patent. All cited references fall in
`
`the field of art of the invention (interventional cardiology procedures) (Exh. 1001,
`
`1:39-43), or are reasonably pertinent to such art. They are also directed to the same
`
`problems that the elements of the claimed invention address. A summary of the
`
`references and the elements to which the references apply follows. U.S. Pub. No.
`
`2004/0236215 (“Mihara”) (Exh. 1009) is an application published on
`
`November 25, 2004, prior to the earliest filing date the benefit of which is claimed
`
`by the ‘032 patent and, thus, qualifies as prior art under § 102(b). The Mihara
`
`publication discloses a “catheter for penetrating a stenotic lesion occurred in a
`
`lumen in a human body, including: a linear wire; and a tubular body placed on a
`
`distal end side of the wire and allowing a guide wire to be inserted through its
`
`hollow portion.” (Exh. 1009, Abstract).
`
`32. Takahashi, New Method to Increase Backup Support of a 6 French
`
`Guiding Coronary Catheter, Catheterization and Cardiovascular Interventions
`
`63:452-456 (2004) (“Takahashi”) (Exh. 1020) is directed to a method for deep-
`
` 15
`
`

`
`Page 16 of 40
`
`
`
`
`
`seating a guide catheter beyond the ostium for purposes of providing backup
`
`support during interventional cardiology procedures. I have been informed by
`
`counsel that Takahashi is prior art to the ‘032 patent under §102(b) because it was
`
`published more than one year prior to the May 6, 2006 filing date of the ‘032
`
`patent. The method disclosed by Takahashi involves the insertion of a 5 French
`
`guide catheter extension through a 6 French guide catheter, whereby the resulting
`
`difference in diameters is not more than one French. Accordingly, this disclosure
`
`of Takahashi is within the claimed range of dependent claims 8 and 17.
`
`V.
`
`Summary of Opinions
`
`33. A number of prior art references, including those discussed below,
`
`show that the various claim elements of the ‘032 patent were well known both
`
`individually and in combination in the prior art. To the extent that any of the claim
`
`limitations are not explicitly disclosed in one reference, such limitations could be
`
`found by one of ordinary skill in one or more of the other references. As such, in
`
`my opinion, the asserted claims would have been in the possession of or obvious to
`
`one of ordinary skill in the art from the disclosures in one or more of certain prior
`
`art references.
`
`A. Claims 1, 2, 3, 4, 11 and 13 are anticipated in view of Mihara
`under § 102(b).
`
`34.
`
`It is my opinion that each of independent claims 1 and 11 and
`
`dependent claims 2, 3, 4, and 13 are invalid as anticipated under § 102(b) over
`
`Mihara. I address each element of those claims in Paragraphs 63-89 of this
`
`Declaration.
`
` 16
`
`

`
`Page 17 of 40
`
`
`
`
`
`35. The Mihara reference is analogous art to the ‘032 patent at least
`
`because it is within the same field of endeavor as the invention of the ‘032 patent.
`
`Further, the Mihara is reasonably pertinent to the problem addressed in the ‘032
`
`patent claims. I address the issue of analogous art in Paragraphs 54-55.
`
`B. Claims 1, 2, 3, 4, 11, and 13 are rendered obvious under § 103(a)
`over Mihara in view of the knowledge of one of skill in the art.
`
`36.
`
`It is my opinion that each of claims 8 and 17 are invalid as obvious
`
`under § 103(a) over Mihara in further view of the knowledge of one of skill in the
`
`art at the time of the claimed invention. I address each element of those claims in
`
`Paragraphs 33 and 61-62 of this Declaration.
`
`37. One of ordinary skill in the art would have been motivated to modify
`
`Mihara in view of what was well known in the art to achieve the alleged inventions
`
`of the ‘032 patent. The issue of motivation to modify is addressed in Paragraphs
`
`61-62 and 90. I address the relevant level of skill in the art at Paragraphs 27-30.
`
`C. Claims 8 and 17 are rendered obvious under § 103(a) over Mihara
`in view of the Takahashi article.
`
`38.
`
`It is my opinion that each of claims 8 and 17 are invalid as obvious
`
`under § 103(a) over Mihara in further view of the Takahashi article. I address each
`
`element of those claims in Paragraphs 91-95 of this Declaration.
`
`39. The Takahashi article publication is analogous art to the ‘032 patent in
`
`that it falls within the same field of endeavor as the invention of the ‘032 patent.
`
`Further, the reference is reasonably pertinent to the alleged problem addressed by
`
`the ‘032 patent. I address the issue of analogous art in Paragraphs 56-58.
`
` 17
`
`

`
`Page 18 of 40
`
`
`
`
`
`40. One of ordinary skill in the art would have been motivated to modify
`
`Mihara with the teachings of Takahashi to achieve the alleged inventions of the
`
`‘032 patent. The issue of combinability is addressed in Paragraphs 33, 61-62 and
`
`91-95.
`
`VI. Legal Principles Used In Analysis
`
`41.
`
`I understand that my analysis requires an understanding of the scope
`
`of the ‘032 claims. I understand that claims subject to inter partes review are given
`
`the “broadest reasonable construction in light of the specification of the patent in
`
`which it appears.” 42 C.F.R. § 42.100(b).
`
`42.
`
`I understand that a claim is invalid if it is anticipated or obvious. I
`
`understand that anticipation of a claim requires that every element of a claim is
`
`expressly or inherently disclosed in a single prior art reference.
`
`43.
`
`I understand that obviousness analysis involves comparing a claim to
`
`the prior art to determine whether the claimed invention would have been obvious
`
`to a person of ordinary skill in the art in view of the prior art and in light of the
`
`general knowledge in the art. I also understand when a person of ordinary skill in
`
`the art would have reached the claimed invention through routine experimentation,
`
`the invention may be deemed obvious.
`
`44.
`
`I also understand that obviousness can be established by combining or
`
`modifying the teachings of the prior art. Specific teachings, suggestions, or
`
`motivations to combine any first or primary prior art reference with a second prior
`
`art reference can be explicit or implicit, but must have existed before the ‘032
`
`patent was filed. I understand that the references themselves may be one source of
`
` 18
`
`

`
`Page 19 of 40
`
`
`
`
`
`a specific teaching or suggestion to combine features of the prior art, but that such
`
`suggestions or motivations to combine art may come from other sources as well.
`
`Specifically, the source may include logic, judgment, and common sense available
`
`to a person of ordinary skill rather than explicit statements in the prior art. I
`
`understand that it is not proper to combine references when there is a teaching
`
`away of such a combination. However, a reference’s mere disclosure of more than
`
`one alternative does not constitute teaching away from any of these alternatives.
`
`45.
`
`I further understand that whether there is a reasonable expectation of
`
`success from combining references in a particular way is also relevant to the
`
`analysis. I understand there may be a number of rationales that may support a
`
`conclusion of obviousness, including:
`
` Combining prior art elements according to known methods to yield
`
`predictable results;
`
` Substitution of one known element for another to obtain
`
`predictable results;
`
` Use of known technique to improve similar devices (methods, or
`
`products) in the same way;
`
` Applying a known technique to a known device (method, or
`
`product) ready for improvement to yield predictable results;
`
` “Obvious to try”—choosing from a finite number of identified,
`
`predictable solutions, with a reasonable expectation of success;
`
` Known work in one field of endeavor may prompt variations of it
`
`for use in either the same field or a different one based on design
`
` 19
`
`

`
`Page 20 of 40
`
`
`
`
`
`incentives or other market forces if the variations are predictable to
`
`one of ordinary skill in the art; or
`
` Some teaching, suggestion, or motivation in the prior art that
`
`would have led one of ordinary skill to modify the prior art
`
`reference or to combine prior art teachings to arrive at the claimed
`
`invention.
`
`46.
`
`I understand that it is not proper to use hindsight in analyzing
`
`combinations. My analysis of the prior art is determined at the time the invention
`
`was made.
`
`47.
`
`I understand that, for a reference to be used to show a claim is
`
`obvious, the reference can, as here, be analogous art to the claimed invention. See
`
`In re Bigio, 381 F.3d 1320, 1325 (Fed. Cir. 2004); KSR Int’l Co. v. Teleflex Inc.,
`
`550 U.S. 398, 420 (2007). I understand that a reference is analogous to the claimed
`
`invention if the reference is from the same field of endeavor as the claimed
`
`invention, even if it addresses a different problem, or the reference is reasonably
`
`pertinent to the problem faced by the inventor, even if it is not in the same field of
`
`endeavor as the claimed invention. I understand that a reference is reasonably
`
`pertinent based on the problem faced by the inventor as reflected in the
`
`specification, either explicitly or implicitly.
`
`VII. Claim Terms
`
`48. Based on my review of the ‘032 patent, there are certain terms used in
`
`that patent that are used in the interventional cardiology device field and have
`
`particular meaning in that field. I applied such constructions where applicable, and
`
` 20
`
`

`
`Page 21 of 40
`
`
`
`
`
`in all other instances I used what I believe to be the broadest reasonable
`
`construction of the claim terms, read in the context of the patent.
`
`1.
`
`“rail structure without a lumen”
`
`49.
`
`I agree with the statements made in the Petition that the term “rail
`
`structure without a lumen.” The word “rail” only appears in the specification of the
`
`‘032 patent twice. The first reference appears in the Summary of the Invention
`
`regarding a “guidewire rail segment” which is defined as “permit[ing] delivery
`
`without blocking the use of the guide catheter.” (Id., 2:65-66). The other reference
`
`to “rail” appears in the description of Fig. 17 as being “a plan view of a coaxial
`
`guide catheter having a longer rail segment.” This description fails to offer any
`
`further explanation as to which portion(s) of Figure 17 constitute the “rail
`
`segment,” or what it is that the “rail segment” is “longer” than. Moreover, I agree
`
`that under the broadest reasonable standard no support exists for the “rail without a
`
`lumen” to be any particular structure. For example, the 032 specification does not
`
`specify that the rail portion should be the “tapered inner catheter,” “full
`
`circumference portion,” “cutout potion,” “reinforced portion,” “hemicylindrical
`
`portion,” “second full circumference portion”, “arcuate portion,” “braid or coil
`
`reinforcement,” “most proximal portion of braid or coil reinforcement,” “relief
`
`cut,” “hemi-tube portion,” “single cuts,” “double cuts,” “connector hub,” “funnel
`
`portion,” or “grip portion,” to name a few.
`
`50. Given this lack of clarity, a

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket